Carmot Therapeutics: Funding, Investors & Team (Oct 2026)
Carmot Therapeutics gives medications to treat incendiary, metabolic, and neurological infections. They utilize their protected innovation, Chemotype Evolution, to address the crucial reasons for sickness and speed the revelation of infection changing treatments. Carmot Therapeutics is settled in San Francisco, California and was established in 2008.
Carmot Therapeutics has raised $160M across 1 funding round on record, the most recent a Series D of $160M announced in Jul 2022.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Carmot Therapeutics Company Profile and Key Stats
Latest funding round on record: Jul 2022.
Carmot Therapeutics Funding Rounds
Carmot Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Carmot Therapeutics Funding Compared to Other Biotechnology Startups
Carmot Therapeutics' latest round of $160M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Carmot Therapeutics in Biotechnology and San Francisco
Companies Similar to Carmot Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Carmot Therapeutics Funding FAQs
What does Carmot Therapeutics do?
Carmot Therapeutics gives medications to treat incendiary, metabolic, and neurological infections. They utilize their protected innovation, Chemotype Evolution, to address the crucial reasons for sickness and speed the revelation of infection changing treatments. Carmot Therapeutics is settled in San Francisco, California and was established in 2008.
How much funding has Carmot Therapeutics raised?
Carmot Therapeutics has raised $160M across 1 round on record. The most recent is a Series D of $160M announced in Jul 2022.
When did Carmot Therapeutics last raise funding?
Carmot Therapeutics' most recent funding round on record is a Series D of $160M, announced in Jul 2022.
Who is the CEO of Carmot Therapeutics?
Stig K Hansen is listed as CEO at Carmot Therapeutics.
Where is Carmot Therapeutics headquartered?
Carmot Therapeutics is based in San Francisco, California, United States.
How many employees does Carmot Therapeutics have?
Carmot Therapeutics is in the 1-10 employee band.
How does Carmot Therapeutics' funding compare to other Biotechnology startups?
Carmot Therapeutics' latest round of $160M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Carmot Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Carmot Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.